MedTrace Logo

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

NCT03884608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-11-22

No results posted yet for this study

Summary

The purpose of this registry is to prospectively assess outcomes of device-treated ventricular tachyarrhythmias and all-cause mortality in non-ischemic cardiomyopathy patients indicated for ICD or CRT-D implantation for the primary prevention of sudden cardiac death. Differences in outcomes will be evaluated by sex and by device type.

Conditions

  • Cardiomyopathies
  • Gender
  • Implantable Defibrillator User

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • Biotronik, Inc.

    lead INDUSTRY

Principal Investigators

  • Valentina Kutyifa, MD, PhD · University of Rochester

  • Jeanne Poole, MD · University of Washington

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2024-11-19
Completion
2024-11-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884608 on ClinicalTrials.gov